GlassScriptPhysician profile
Thomas J Rizzo
NPI 1194708271
$4,372.59
in general payments reported to CMS, 2019-2025
15 companies · $462 in 2025
The $462 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2020: $18.09 · 2021: $58.19 · 2022: $408 · 2023: $167 · 2024: $3,153 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,345 · Food and Beverage: $1,437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,345.04 |
| Food and Beverage | $1,436.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,789.24 | 2022-2025 | Prostep, Prostep Mica, Ortholoc 2 Lapifuse |
| Organogenesis INC. | $509.53 | 2020-2025 | Puraply, Simplimax, Via Matrix |
| Treace Medical Concepts, INC. | $366.67 | 2023-2024 | |
| Medshape, INC. | $150.00 | 2024 | Eclipse |
| Novastep INC. | $140.92 | 2025 | Nexis |
| Paratek Pharmaceuticals, INC. | $69.55 | 2024-2025 | Nuzyra |
| Heron Therapeutics, INC. | $55.34 | 2021-2022 | |
| Trilliant Surgical LLC. | $55.01 | 2019 | |
| Zimmer Biomet Holdings, INC. | $51.36 | 2019 | |
| Baudax Bio INC. | $43.98 | 2021 | |
| Mimedx Group, INC. | $32.62 | 2025 | |
| Convatec INC. | $31.63 | 2024-2025 | |
| Surgenex LLC | $26.83 | 2025 | Surgraft, Surmatrix, Pellograft |
| Smith+Nephew, INC. | $26.52 | 2022 | |
| Orthofix Medical, INC. | $23.39 | 2023 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Rizzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.